Hong Kong stock market abnormal movement | Xie Ruilin (00417.HK) surges over 45% again, cumulative increase of over 200% this week, Board of Directors says they are unaware of the reasons for the fluctuation in stock price.

According to the Securities Times app, Sino Biopharmaceutical (00417.HK) has risen by over 45% again, with a cumulative increase of over 200% this week. As of the time of this report, the stock has risen by 46.76%, closing at 2.04 Hong Kong dollars, with a trading volume of 12.1774 million Hong Kong dollars.